Thor Medical ASA Statistics
Total Valuation
OSL:TRMED has a market cap or net worth of NOK 754.58 million. The enterprise value is 631.93 million.
Market Cap | 754.58M |
Enterprise Value | 631.93M |
Important Dates
The last earnings date was Friday, March 28, 2025.
Earnings Date | Mar 28, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
OSL:TRMED has 314.41 million shares outstanding. The number of shares has increased by 34.90% in one year.
Current Share Class | n/a |
Shares Outstanding | 314.41M |
Shares Change (YoY) | +34.90% |
Shares Change (QoQ) | +1.36% |
Owned by Insiders (%) | 3.00% |
Owned by Institutions (%) | 1.73% |
Float | 154.56M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | 2.00 |
P/TBV Ratio | 13.95 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -14.97 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -26.20 |
Financial Position
The company has a current ratio of 5.67, with a Debt / Equity ratio of 0.00.
Current Ratio | 5.67 |
Quick Ratio | 5.49 |
Debt / Equity | 0.00 |
Debt / EBITDA | n/a |
Debt / FCF | -0.03 |
Interest Coverage | -448.28 |
Financial Efficiency
Return on equity (ROE) is -13.86% and return on invested capital (ROIC) is -9.01%.
Return on Equity (ROE) | -13.86% |
Return on Assets (ROA) | -7.37% |
Return on Invested Capital (ROIC) | -9.01% |
Return on Capital Employed (ROCE) | -11.22% |
Revenue Per Employee | n/a |
Profits Per Employee | -8.44M |
Employee Count | 2 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +122.43% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +122.43% |
50-Day Moving Average | 2.41 |
200-Day Moving Average | 1.83 |
Relative Strength Index (RSI) | 51.93 |
Average Volume (20 Days) | 1,913,215 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -43.93M |
Pretax Income | -42.64M |
Net Income | -42.21M |
EBITDA | -41.55M |
EBIT | -43.93M |
Earnings Per Share (EPS) | -0.18 |
Balance Sheet
The company has 123.39 million in cash and 737,000 in debt, giving a net cash position of 122.65 million or 0.39 per share.
Cash & Cash Equivalents | 123.39M |
Total Debt | 737,000 |
Net Cash | 122.65M |
Net Cash Per Share | 0.39 |
Equity (Book Value) | 337.14M |
Book Value Per Share | 1.20 |
Working Capital | 107.01M |
Cash Flow
In the last 12 months, operating cash flow was -23.98 million and capital expenditures -140,000, giving a free cash flow of -24.12 million.
Operating Cash Flow | -23.98M |
Capital Expenditures | -140,000 |
Free Cash Flow | -24.12M |
FCF Per Share | -0.08 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
OSL:TRMED does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -34.90% |
Shareholder Yield | -34.90% |
Earnings Yield | -5.59% |
FCF Yield | -3.20% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |